Gerresheimer is a manufacturer of insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for the healthcare industry.
Business Model:
Revenue: $1.8B
Employees: 10,001-999,999
Gerresheimer was acquired by
Blackstone Group.
The acquisition happend on 2004-11-11.
Details of the transaction were not public
Address: Klaus-Bungert-Straße 4
City: Düsseldorf
State: north rhine-westphalia
Zip: 40468
Country: DE
Gerresheimer is a manufacturer of insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for the healthcare industry.
Contact Phone:
Contact Email:
Listed Exchange:
FRA
Ticker Symbol:
GXI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2022 | Adamant Health | Seed Round | 0 |
6/2022 | Adamant Health | Seed Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
7/2018 | Sensile Medical | |
7/2015 | Centor |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|